The AIBP deficiency exacerbates AD-related neuropathology; in APP/PS1 mouse models, loss of AIBP results in increased Aβ plaque burden, microglial activation and increased neuronal cell death [18]. This evidence concerns the gene APP and Alzheimer disease.